Saxon Smith

29PUBLICATIONS
42CO-AUTHORS
Pharmaceutical delivery technologiesChild and adolescent developmentNanomedicinePredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 14, 2024
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patients.

Peter Foley, Patrick D Mahar, Saxon D Smith

|Oct 02, 2023
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.

Alexander Egeberg, Lars Erik Kristensen, Luis Puig

|Aug 03, 2023
Outcomes in organ transplants from donors with melanoma: a systematic review.

William Hao Syuen Ng, David John Curchin, Stella McGinn

|Jun 23, 2023
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.

Saxon D Smith, Alexandros Stratigos, Matthias Augustin

|Oct 19, 2021
Cannabinoids interaction with transient receptor potential family and implications in the treatment of rosacea.

Kieran B Garbutcheon-Singh, Saxon D Smith

Pageof 5